| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |